Transforming Pharmacovigilance: Advanced Automation Use Cases
A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.

Denny Lorenz
Managing Director and Principal Consultant
Lorenz Bratti GmbH

A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempora.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempora.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempora.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempora.
Up to now, AI technology has had to be painstakingly ‘trained’ in what to look for.
In the ever-evolving world of pharmaceuticals, a leading company has embarked on a transformative journey by moving its regulatory operations to the cloud.
In today's rapidly evolving landscape of medical affairs, stakeholder engagement ...
In the ever-evolving landscape of data management, the life sciences ...
In the highly competitive pharmaceutical industry, efficiently managing medical information ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved